FINAL HOURS ⚡ Don't miss your chance to save big!

Register for only $99 to CNBC Healthy Returns

FINAL HOURS ENDING TODAY: Take advantage of this one-time offer & save BIG! Book your virtual seat for only $99. Use code: FLASH REGISTER AGENDA HIGHLIGHTS INCLUDE: J&J CEO'S BIG PLANS FOR A HEALTHIER FUTURE with Joaquin Duato, Johnson & Johnson CEO   In his first sit-down interview, Johnson & Johnson's new CEO Joaquin Duato shares his vision for the future of the world's largest healthcare company and how he plans to continue to drive growth across the business. THE PROMISE AND FUTURE OF RNAi with Dr. Yvonne Greenstreet, Alnylam Pharmaceuticals CEO   The global RNAi therapeutic market is expected to top $11.5 billion by 2027, on the potential to cure a wide range of severe and debilitating diseases. Dr. Yvonne Greenstreet walks us through the R&D breakthroughs and 2022 pipeline for this Nobel-winning "gene-silencing" technology. WALGREENS: A GROWING HEALTH CARE FOOTPRINT with Rosalind Brewer, Walgreens Boots Alliance CEO   Major drugstore chains like Walgreens served as trusted health care hubs during the Covid-19 pandemic. It's where Americans turned for testing, vaccinations, and hard to find goods close to home. In a rare interview, one year into her tenure, CEO Roz Brewer shares her vision for how Walgreens can bridge the care gap for patients and their caregivers in our fragmented health system.    2022 BIOTECH INVESTING FORECAST with Dr. Christiana Bardon, MPM Capital Co-Managing Partner   After what has undoubtedly been a very rocky 12 months for biotech, is the sector ripe for a comeback?  Biotech investor and Harvard-trained medical doctor, Dr. Christiana Bardon thinks advances in gene therapies, robust drug pipelines and an improving regulatory landscape will be key industry drivers for the road ahead.  TRANSFORMATIVE HEALTH TECH IDEAS FOR 2022 with Deena Shakir, Lux Capital Partner, and Mohamad Makhzoumi, NEA Managing General Partner, Healthcare Last year was a banner year for digital health with nearly $60 billion invested into the sector globally. And VCs remain bullish on the long-term potential for health tech across multiple disruptive sectors including health IT, biopharma, medical devices and telehealth. Two investors share their top tech picks for 2022 and beyond.    For more information about this event and the full agenda, click here. REGISTER Think a friend or colleague should receive this invitation? Please feel free to share the registration link above.   If you have any questions or want to submit a question to one of our speakers, please reach out to events@cnbc.com. Terms of Service | Privacy Policy | CNBC Events Policy | Unsubscribe © 2022 CNBC LLC. All rights reserved. A property of NBCUniversal Media, LLC 1 CNBC Plaza, 900 Sylvan Avenue, Englewood Cliffs, NJ 07632